Advertisement
Advertisement
Nicorette Invisi Transdermal Patch

Nicorette Invisi Transdermal Patch Side Effects

nicotine

Manufacturer:

JNTL

Distributor:

Zuellig Pharma
Full Prescribing Info
Side Effects
Most of the undesirable effects reported by the subjects occur during the early phase of treatment and are mainly dose-dependent. Allergic reactions (including symptoms of anaphylaxis) occur rarely during use of Nicorette Invisi Transdermal Patch.
About 20% of users experienced mild local skin reactions during the first weeks of treatment.
Like all medicines, Nicorette Invisi Transdermal Patch can cause side effects. As many of the effects are due to nicotine, they can also occur when nicotine is obtained by smoking.
Effects related to smoking (nicotine withdrawal): The patient may experience unwanted effects because the patient have stopped smoking, or the patient have reduced the amount of nicotine being taken. These effects include: Dizziness, Headache, Irritability or aggression, Feeling low, Anxiety Restlessness, Poor concentration, Increased appetite or weight gain, Urge to smoke (craving), Sleeplessness or sleep disturbance, Lowering of heart rate.
Reported Side Effects: The commonly reported side effects are rash and hives.
Uncommonly reported side effects include fast heartbeat, application site reactions, body weakness, chest discomfort and pain, general feeling of being unwell, muscle pain, abnormal dream, shortness of breath, increase sweating, flushing, high blood pressure.
Undesirable effects arise from combination therapy (use of transdermal patch and another oral format together) may differ from monotherapy whereby the undesirable effects may be attributed to the pharmaceutical form. The frequency of the undesirable effects is comparable with what is given in the package insert for the respective product.
If the patient notice these or any other unwanted effects not listed in this package insert, tell a healthcare professional.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement